Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3NIH 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 309Neoplasms 269Prostatic Neoplasms 189Precursor Cell Lymphoblastic Leukemia-Lymphoma 186Lymphoma 184Leukemia, Lymphocytic, Chronic, B-Cell 161Melanoma 158Leukemia 154Lymphoma, Non-Hodgkin 149Leukemia, Myeloid, Acute 149Brain Neoplasms 143Carcinoma, Non-Small-Cell Lung 141Lymphoma, Large B-Cell, Diffuse 128Colonic Neoplasms 128Lymphoma, Follicular 123Burkitt Lymphoma 119Ovarian Neoplasms 117Lung Neoplasms 116Glioblastoma 116Lymphoma, Mantle-Cell 114Unspecified Adult Solid Tumor, Protocol Specific 107Rectal Neoplasms 103Sarcoma 102Multiple Myeloma 102Gliosarcoma 102Hodgkin Disease 97Carcinoma, Renal Cell 97Lymphoma, B-Cell, Marginal Zone 96Astrocytoma 95Carcinoma, Ovarian Epithelial 93

Interventions

Etanercept 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × NIH × Vasculitis × Clear all
NCT00001156 2017-07-02

Assessment of Patients With Multiple Sclerosis (MS)

National Institutes of Health Clinical Center (CC)

Completed
1,388 enrolled

Herpesviridae Infections, Multiple Sclerosis, Vasculitis, HTLV-I Infections, Paraparesis, Tropical Spastic, Epstein-Barr Virus Infections

NCT00001901 2008-03-04

Etanercept to Treat Wegener's Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled

Vasculitis, Granulomatosis with Polyangiitis

NCT00005007 2007-12-28

Etanercept for Wegener's Granulomatosis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Phase 2/3 Completed
181 enrolled

Vasculitis, Granulomatosis with Polyangiitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡